Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
about
Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexNovel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.Roadmap of miR-122-related clinical application from bench to bedside.Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.Clinical drug research in chronic central neurodegenerative disorders.Amyloid β oligomers (AβOs) in Alzheimer's disease.Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential.
P2860
Q35044486-C6D890BB-7128-49FD-AF22-6D67F40A79ADQ37501943-4BA15D30-BB56-4737-B222-1B7E43F32AC4Q38172567-89DBDCBD-5884-4FE3-A00F-62734A6C07F4Q38184618-3FAF045F-E3A7-4489-BE90-F6F99AFBC2AAQ38763831-D8E6C568-62DE-466B-AFAB-7F306E39CBFBQ47339779-07DED7A1-2C91-46BC-8E1C-15556930E139Q48139601-7BEB5CC7-5311-4BD8-A9A6-AC8E2C50C521
P2860
Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Clinical trials of amyloid-bas ...... beginning or beginning of end?
@en
type
label
Clinical trials of amyloid-bas ...... beginning or beginning of end?
@en
prefLabel
Clinical trials of amyloid-bas ...... beginning or beginning of end?
@en
P2093
P2860
P1476
Clinical trials of amyloid-bas ...... beginning or beginning of end?
@en
P2093
Yahong Liu
Yongjun Jiang
Zhaojun Wang
P2860
P304
P356
10.1517/14712598.2013.838555
P407
P577
2013-09-22T00:00:00Z